Position in AGIO
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$2,004,664
+$569,109 QoQ
Shares Held
59,257
+12.4% QoQ
Ownership
0.100%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2023
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AGIO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Headlands Technologies LLC holds $48,170,220 across 76 Biotechnology names. AGIO ranks #3 (4.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IBRX |
ImmunityBio, Inc.
|
397,170 | $3,046,293 | |
| 2 | NKTR |
Nektar Therapeutics
|
28,244 | $2,032,155 | |
| 3 | AGIO |
Agios Pharmaceuticals, Inc.
This page
|
59,257 | $2,004,664 | |
| 4 | VERA |
Vera Therapeutics, Inc.
|
49,223 | $1,980,241 | |
| 5 | MLTX |
MoonLake Immunotherapeutics
|
97,133 | $1,810,559 | |
| 6 | GPCR |
Structure Therapeutics Inc.
|
37,156 | $1,790,919 | |
| 7 | VKTX |
Viking Therapeutics, Inc.
|
49,146 | $1,599,210 | |
| 8 | NVAX |
Novavax Inc
|
189,675 | $1,543,954 |
All Filings in AGIO
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,004,664 | 59,257 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,435,555 | 52,739 | Shares | Sole | 2026-02-13 | |
| 2025-06-30 | $420,539 | 12,644 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $313,949 | 10,715 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $878,544 | 26,736 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $610,779 | 13,747 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $493,724 | 11,450 | Shares | Sole | 2024-08-07 | |
| 2023-12-31 | $198,047 | 8,893 | Shares | Sole | 2024-02-02 | |
| 2023-09-30 | $223,665 | 9,037 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $194,954 | 6,884 | Shares | Sole | 2023-08-03 | |
| No filing history on record for this holder in this stock. | ||||||